Showing results (1-10 of 169) with videos related to
Sort By:
Pageof 17
Methods in Enzymology|October 19, 2006
Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategiesDavid A Kocisko, Byron CaugheyJournal of Virology|December 28, 2005
Mefloquine, an antimalaria drug with antiprion activity in vitro, lacks activity in vivoDavid A Kocisko, Byron CaugheyAntimicrobial Agents and Chemotherapy|September 29, 2006
Enhanced antiscrapie effect using combination drug treatmentDavid A Kocisko, Byron Caughey, John D Morrey, et al.Journal of Wildlife Diseases|April 12, 2012
Assessment of prospective preventive therapies for chronic wasting disease in mule deerLisa L Wolfe, David A Kocisko, Byron Caughey, et al.The Journal of General Virology|July 23, 2004
Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in miceDavid A Kocisko, John D Morrey, Richard E Race, et al.Journal of Virology|September 13, 2003
New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural productsDavid A Kocisko, Gerald S Baron, Richard Rubenstein, et al.Antimicrobial Agents and Chemotherapy|January 27, 2006
A porphyrin increases survival time of mice after intracerebral prion infectionDavid A Kocisko, Winslow S Caughey, Richard E Race, et al.Antimicrobial Agents and Chemotherapy|August 22, 2007
Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activityWinslow S Caughey, Suzette A Priola, David A Kocisko, et al.Neuroscience Letters|July 26, 2005
Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapieDavid A Kocisko, Abbi L Engel, Kristin Harbuck, et al.British Medical Bulletin|October 3, 2003
Prion protein conversions: insight into mechanisms, TSE transmission barriers and strainsByron CaugheyPageof 17